Wheaton Precious Metals Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Wheaton Precious Metals Corp trades at $103.33 (market cap $46.54B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Wheaton Precious Metals Corp pays a 0.75% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Wheaton Precious Metals Corp nearer its low. Which is the better fit depends on your goals.
| WPM | XBI | |
|---|---|---|
Market Cap | $46.54B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $165.72 | $164.28 |
52-Week Low | $91.00 | $85.16 |
Enterprise Value | $44.39B | — |
Dividend Yield | 0.75% | — |
Trailing returns across standard periods
Latest headlines on both assets
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →